Direct induction by melanoma, prostate cancer and Ewing's sarcoma tumour cells of osteoclast formation by a RANKL-independent mechanism

Direct induction by melanoma, prostate cancer and Ewing's sarcoma tumour cells of osteoclast formation by a RANKL-independent mechanism

Opis bibliograficzny
Główni autorzy:	Lau, Y, Sabokbar, A, Giele, H, Gibbons, C, Cerundolo, V, Athanasou, N
Format:	Conference item
Wydane:	2005

Podobne zapisy

Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma.
od: Lau, Y, i wsp.
Wydane: (2007)

Ewing sarcoma cells express RANKL and support osteoclastogenesis
od: Taylor, R, i wsp.
Wydane: (2011)

Ewing sarcoma cells express RANKL and support osteoclastogenesis.
od: Taylor, R, i wsp.
Wydane: (2011)

Ewing's sarcoma cells promote osteoclast formation
od: Taylor, R, i wsp.
Wydane: (2010)

Rankl-independent induction of human osteoclast formation and bone resorption by TGF-beta
od: Itonaga, I, i wsp.
Wydane: (2002)

RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer.
od: Lau, Y, i wsp.
Wydane: (2007)

Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
od: Sun, S, i wsp.
Wydane: (2006)

Involvement of RANKL-dependent/independent mechanisms in osteoclast formation in aseptic loosening
od: Sabokbar, A, i wsp.
Wydane: (2001)

Sarcoma-associated macrophages differentiate into osteoclastic bone-resorbing cells
od: Lau, Y, i wsp.
Wydane: (2004)

Localized Ewing sarcoma of the tibia.
od: Kashima, T, i wsp.
Wydane: (2013)

IL-6 induces human osteoclast formation and bone resorption independent of RANK/RANKL interaction
od: Kudo, O, i wsp.
Wydane: (2001)

Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism.
od: Kudo, O, i wsp.
Wydane: (2003)

Human osteoclast formation and bone resorption by a mechanism independent of RANK/RANKL: Role of IL-6 and IL-11.
od: Kudo, O, i wsp.
Wydane: (2001)

Transforming growth factor-beta induces osteoclast formation in the absence of RANKL.
od: Itonaga, I, i wsp.
Wydane: (2004)

Heterogeneity in Ewing sarcoma
od: Branford White, HA
Wydane: (2014)

RANKL and M-CSF are required for osteoclast differentiation by macrophages in breast cancer
od: Danks, L, i wsp.
Wydane: (2003)

RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II.
od: Hemingway, F, i wsp.
Wydane: (2011)

RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II.
od: Hemingway, F, i wsp.
Wydane: (2011)

Osteoclast differentiation in Paget's disease is hypersensitive to RANKL.
od: Neale, S, i wsp.
Wydane: (2000)

Metal wear-induced pseudotumour following an endoprosthetic knee replacement for Ewing sarcoma
od: Craig, R, i wsp.
Wydane: (2017)

Malignant melanoma and bone resorption.
od: Lau, Y, i wsp.
Wydane: (2006)

Human mesenchymal tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells.
od: Yang, T, i wsp.
Wydane: (2002)

RANKL-independent osteoclastogenesis in Paget's disease
od: Jones, F, i wsp.
Wydane: (2008)

Targeted treatment of Ewing sarcomas: Current status
od: Hassan, A
Wydane: (2013)

RANKL plays an important role as activator of osteoclastic bone resorption in acute Charcot osteoarthropathy
od: Petrova, N, i wsp.
Wydane: (2007)

Human tumour associated macrophages are capable of osteoclastic differentiation and bone resorption
od: Quinn, J, i wsp.
Wydane: (1997)

Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.
od: Knowles, H, i wsp.
Wydane: (2010)

Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation.
od: Kudo, O, i wsp.
Wydane: (2002)

Secreted frizzled-related protein inhibits TNFalpha- or RANKL-dependent osteoclast formation
od: Hausler, K, i wsp.
Wydane: (2003)

Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
od: Häusler, K, i wsp.
Wydane: (2004)

Combinatorial drug screening identifies Ewing sarcoma-specific sensitivities
od: Radic-Sarikas, B, i wsp.
Wydane: (2016)

Effect of corticosteroids on human osteoclast formation and activity.
od: Hirayama, T, i wsp.
Wydane: (2002)

The effect of corticosteroids on human osteoclast formation and activity
od: Hirayama, T, i wsp.
Wydane: (2000)

Humoral factors act directly on circulating osteoclast precursors to control osteoclast formation
od: Hirayama, T, i wsp.
Wydane: (2000)

Formation and isolation of human osteoclasts
od: Kudo, O, i wsp.
Wydane: (2001)

Malignant neck mass in disguise - atypical presentation of extraskeletal Ewing's sarcoma
od: Poh, Nuan Leng, i wsp.
Wydane: (2022)

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
od: Jain, A, i wsp.
Wydane: (2017)

Osteoclast formation in Gorham-Stout disease
od: Hirayama, T, i wsp.
Wydane: (2000)

Subungual melanoma with osteocartilaginous differentiation.
od: Giele, H, i wsp.
Wydane: (2003)

Osteoclast-like cells in soft tissue leiomyosarcomas.
od: Gibbons, C, i wsp.
Wydane: (2010)